Lakefront Biotherapeutics N.V.
LKFT | NASDAQ
$32.28
-$0.05 (-0.15%)
At close: Oct 30, 2026, 4:00 PM ET
$32.32
+$0.04 (+0.12%)
Pre-market:
Nov 2, 2026, 9:25 AM ET
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 |
|---|---|---|---|---|---|
Net Income | 596.64M | 488.78M | 474.29M | -307.86M | -105.75M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | -907.06M | -964.27M | -928.83M | -115.04M | -57.21M |
Other Non-Cash Items | 117.61M | 173.89M | 235.69M | 251.51M | 54.18M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -907.06M | -964.27M | -928.83M | -115.04M | -57.21M |
Operating Cash Flow | -192.82M | -301.6M | -218.85M | -171.39M | -108.78M |
Capital Expenditures | -4.58M | -8.73M | -8.61M | -7.01M | -4.16M |
Cash Acquisitions | 12.04M | -10.15M | -12.49M | -14.12M | -22.19M |
Purchase of Investments | -1.43B | -3.18B | -3.13B | -2.71B | -1.75B |
Sales Maturities Of Investments | 1.59B | 3.42B | 3.31B | 2.83B | 1.82B |
Other Investing Acitivies | 19.89M | 43.73M | 42.41M | 36.95M | 23.84M |
Investing Cash Flow | 190.86M | 265.57M | 204.07M | 131.45M | 74.71M |
Debt Repayment | -2.17M | -2.77M | -2.26M | -1.86M | -600K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | -2.17M | -2.77M | -2.26M | -1.86M | -600K |
Net Cash Flow | -71.67M | -41.26M | -20.2M | -43.61M | -36.4M |
Free Cash Flow | -197.4M | -310.33M | -227.46M | -178.39M | -112.94M |
Adj. Free Cash Flow | -197.4M | -310.33M | -227.46M | -178.39M | -112.94M |
Maintenance CapEx | -2.42M | -6.57M | n/a | n/a | n/a |
Growth CapEx | -2.16M | -2.16M | n/a | n/a | n/a |
Owner Earnings | -195.23M | -308.17M | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove LKFT